[Skip to content]

EPDA - European Parkinsons Disease Association

EPDA - European Parkinsons Disease Association

EPDA - Awareness

EPDA - Coping Strategies

EPDA - Medical Information

EPDA - Patient Guide

EPDA - Site Map

EPDA - Rewrite Tomorrow

Contact Us |
Login |
Accessibility |
Low graphics |
Text Size: A A A

EUROPEAN PARKINSON'S DISEASE ASSOCIATION

.

Archived news

2006

Search

Search for

EMEA Management Board adopts the 2007 work programme and budgetAt its final meeting for 2006, the Management Board of the European Medicines Agency adopted the work programme and budget in preparation for a sustained level of activity in 2007. 21 December 2006
NCPC's National Funding Survey reveals big pressures on Specialist Palliative Care Services in the NHS and the Voluntary SectorSurvey reveals that the funding from the NHS is being eroded and that promised government commitment to extra funding has not been met. 27 November 2006
NCPC supporting a good death for allChanging Gear - Guidelines for Managing the Last Days of Life in Adults 20 November 2006
Dopamine agonists: Pathological gambling and increased libido are potential class effects of these drugsThe Medicines and Healthcare products Regulatory Agency (MHRA) have recently published a Public Assessent Report on dopamine agonists and pathological gambling, increased libido and hypersexuality. 07 November 2006
Policy makers support Alzheimer Europe's call to make Alzheimer's disease a European public health priorityOn 21 September 2006, in order to celebrate the World Alzheimer's Day, Alzheimer Europe published a pan-European report: 'Who cares? The state of dementia care in Europe', which highlights serious gaps in dementia care. 07 November 2006
New evidence demonstrates use of Stalevo improves quality of life and may provide long-term benefits in patients with Parkinson'Kyoto - October 31, 2006 - New data shows that Stalevo significantly improves quality of life in patients with Parkinson's disease with no or minimal motor fluctuations, when compared to traditional levodopa therapy. In addition, new analysis suggests that patients treated earlier with enhanced levodopa therapy including entacapone experienced a sustained improvement in symptom control that was not achieved when treatment was delayed by 6 months. The new findings were presented today at the 10th Internation 31 October 2006
Rewrite Tomorrow website—European Parkinson's Disease Association launches website for people with advancing Parkinson's disease30 September, 2006 - Ljubljana, Slovenia - The European Parkinson's Disease Association (EPDA), with the support of Medtronic Europe, have launched Rewrite Tomorrow, a website dedicated to raising awareness about advanced Parkinson's disease (PD) and its management. 30 October 2006
Patients get extended internet access to all Roche sponsored clinical trialsSuccessful outcome of discussions between patient groups and industry 26 October 2006
Media perception about interest groups in EU affairsEurActiv and IFJ/EFJ release the results of their survey 19 October 2006
Carers condemn serious gaps in dementia care - Alzheimer's groups campaign for appropriate disease managementOn 21 September 2006, in order to celebrate the World Alzheimer's Day, Alzheimer Europe published a pan-European report: 'Who cares? The state of dementia care in Europe', which highlights serious gaps in dementia care. 21 September 2006

Page: [1] [2] [3] [4]

[ Next » ]